FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2014293735> ?p ?o ?g. }

• W2014293735 endingPage "320" @default.
• W2014293735 startingPage "311" @default.
• W2014293735 abstract "Clinical & Experimental AllergyVolume 15, Issue 4 p. 311-320 Sodium cromoglycate and related drugs M. K. CHURCH, Corresponding Author M. K. CHURCH *Correspondence: Clinical Pharmacology, Centre Block, Southampton General Hospital, Southampton, SO9 4XY †Correspondence: Department of Paediatrics, Brompton Hospital, Fulham Road, London, SW3 6HP.Search for more papers by this authorJ. O. WARNER, Corresponding Author J. O. WARNER *Correspondence: Clinical Pharmacology, Centre Block, Southampton General Hospital, Southampton, SO9 4XY †Correspondence: Department of Paediatrics, Brompton Hospital, Fulham Road, London, SW3 6HP.Search for more papers by this author M. K. CHURCH, Corresponding Author M. K. CHURCH *Correspondence: Clinical Pharmacology, Centre Block, Southampton General Hospital, Southampton, SO9 4XY †Correspondence: Department of Paediatrics, Brompton Hospital, Fulham Road, London, SW3 6HP.Search for more papers by this authorJ. O. WARNER, Corresponding Author J. O. WARNER *Correspondence: Clinical Pharmacology, Centre Block, Southampton General Hospital, Southampton, SO9 4XY †Correspondence: Department of Paediatrics, Brompton Hospital, Fulham Road, London, SW3 6HP.Search for more papers by this author First published: July 1985 https://doi.org/10.1111/j.1365-2222.1985.tb02998.xCitations: 23AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Howell JBL, Altounyan REC. A double blind trial of disodium cromoglycate in the treatment of allergic bronchial asthma. Lancet 1967; 2: 539–42. 2 Brogden RN, Speight TM, Avery GS. Sodium cromoglycate (cromolyn sodium): A review of its mode of action, pharmacology, therapeutic efficacy and use. Drugs 1974; 7: 164–282. 3 Cox JSG. Disodium cromoglycate (FPL 670, “Intal”): a specific inhibitor of reaginic antigen-antibody mechanisms. Nature (London) 1967; 216: 1328–9. 4 Church MK. Cromoglycate-like anti-allergic drugs: A review. Drugs of Today 1978; 14: 281–341. 5 Orr TSC. Recent developments concerning the mast cell and the mode of action of disodium cromoglycate. Acta Allergol 1975; 12 (suppl): 13–29. 6 Orr TSC, Gwilliam J, Cox JSG. Studies on passive cutaneous anaphylaxis in the rat with disodium cromoglycate: II. A comparison of the rat anti-DNP 7Sγ2 and rat reagin induced cutaneous reactions. Immunology 1971; 21: 405–17. 7 Pearce FL, Befus AD, Gauldie J, Bienenstock J. Mucosal mast cells. II. Effects of anti-allergic compounds on histamine secretion by isolated intestinal mast cells. J Immunol 1982; 128: 2481–6. 8 Jeffrey P, Corrin B. Structural analysis of the upper respiratory tract. In: J Bienenstock, ed. Immunology of the lung and upper respiratory tract. New York : McGraw-Hill, 1984: 1–27. 9 Church MK, Young KD. The characteristics of inhibition of histamine release from human lung fragments by sodium cromoglycate, salbutamol and chlorpromazine. Br J Pharmacol 1983; 78: 671–9. 10 Church MK, Holgate ST, Pao GJ-K. Histamine release from mechanically and enzymatically dispersed human lung mast cells: inhibition by salbutamol and cromoglycate. Br J Pharmacol 1983; 79 (suppl.): 374. 11 Flint KC, Leung KBP, Pearce FL, Hudspith BN, Brostoff J, Johnson NM. Human mast cells recovered by bronchoalveolar lavage: their morphology, histamine release and the effects of sodium cromoglycate. Clin Sci 1985; 68: 427–32. 12 Howarth PH, Durham SR, Lee TH, Kay AB, Church MK, Holgate ST. Influence of albuterol, cromolyn sodium and ipratropium bromide on the airway and circulating mediator responses to allergic bronchial provocation in asthma. Am Rev Respir Dis 1985; (in press). 13 Booij-Nord H, Orie NGM, de Vries K. Immediate and late bronchial obstructive reactions to inhalation of house dust and protective effects of disodium cromoglycate and prednisolone. J Allergy Clin Immunol 1971; 48: 344–54. 14 Hegardt B, Pauwels R, Van der Straaten M. Inhibitory effect of KWD 2131, terbutaline and DSCG on the immediate and late allergen-induced bronchoconstriction. Allergy 1981; 36: 115–22. 15 Larsen GL, Shampain MP, Marsh WR, Behrens BL. Animal model of the late asthmatic response to antigen challenge. In: AB Kay, KF Austen, LM Lichtenstein, eds. Asthma: physiology, immunopharmacology and treatment. London : Academic Press, 1984: 245–58. 16 Kay AB, Lee TH. Neutrophil chemotactic peptide of anaphylaxis. J Allergy Clin Immunol 1982; 70: 317–20. 17 Howarth PH, Pao GJ-K, Church MK, Holgate ST. Exercise and isocapnic hyperventilation-induced bronchoconstriction in asthma: relevance of circulating basophils to measurements of plasma histamine. J Allergy Clin Immunol 1984; 73: 391–9. 18 Diaz P, Galleguillos FR, Gonzalez MC, Pantin CFA, Kay AB. Bronchoalveolar lavage in asthma: the effect of disodium cromoglycate (cromolyn) on leucocyte counts, immunoglobulins and complement. J Allergy Clin Immunol 1984; 74: 41–8. 19 Kay AB, Walsh GM, Moqbel GM, MacDonald AJ, Nagakura T, Carroll MP, Richerson MB. Disodium cromoglycate inhibits activation of human inflammatory cells in vitro, (in press). 20 Dixon M, Jackson DM, Richards IM. The action of sodium cromoglycate on 'C fibre endings in the dog lung. Br J Pharmacol 1980; 70: 11–13. 21 Altounyan REC. Inhibition of experimental asthma by a new compound - disodium cromoglycate ‘Intal’. Acta Allergol 1967; 22: 487. 22 Cox JSG, Altounyan REC. Nature and modes of action of disodium cromoglycate (Lomudal). Respiration 1970; 27 (suppl): 292–309. 23 Davies SE. Effect of disodium cromolgycate on exercise-induced asthma. Br Med J 1968; 3: 593–4. 24 Lee TH, Nagy L, Nagakura T, Walport MJ, Kay AB. Identification and partial characterisation of an exercise-induced neutrophil chemotactic factor in bronchial asthma. J Clin Invest 1982; 69: 889–99. 25 Deal EC, Wasserman SI, Soter NA, Ingram RH, McFadden ER. Evaluation of role played by mediators of immediate hypersensitivity in exercise-induced asthma. J Clin Invest 1980; 65: 659–65. 26 Breslin FJ, McFadden ER, Ingram RH. The effects of cromolyn sodium on the airway response to hyperpnoea and cold air in asthma. Am Rev Respir Dis 1980; 122: 11–16. 27 Snashall PD, Lenin C. Mechanism of sulfur dioxide induced bronchoconstriction in man. Am Rev Respir Dis 1976; 113 (abstr.): 87. 28 Butcher BT. Inhalation challenge and pharmacologic studies of toluene di-isocyanate (TDI) sensitive workers. J Allergy Clin Immunol 1979; 64: 146–52. 29 Anderson SD, Schoeffel RE, Altounyan RE, Lindsay DA. Airway reactivity in response to inhalation of ultrasonically nebulised solutions of water and saline in patients with asthma. Paper presented at 7th Asia-Pacific Congress on Diseases of the Chest, Hong Kong , November, 1983. 30 Patel KR. Sodium cromoglycate in histamine and methacholine reactivity in asthma. Clin Allergy 1984; 14: 143–5. 31 Altounyan REC. Review of clinical activity and mode of action of sodium cromoglycate. Clin Allergy 1980; 10 (suppl): 481–9. 32 Jones RM, Horn CR, Lee DV, Brennan SR. Bronchodilator effects of disodium cromoglycate in exercise-induced bronchoconstriction. Br J Dis Chest 1983; 77: 362–9. 33 Pepys J, Hargreave FE, Chan M, McCarthy DS. Inhibitory effects of disodium cromoglycate on allergen-inhalation tests. Lancet 1968; ii: 134–7. 34 Cockcroft DW, Ruffin RE, Dolovich J, Hargreave FE. Allergen-induced increase in non-allergic bronchial reactivity. Clin Allergy 1977; 7: 503–13. 35 Warner JO. Bronchial provocation tests. Arch Dis Childh 1977; 52: 750–1. 36 Brompton Hospital/Medical Research Council Collaborative Trial. Longterm study of disodium cromoglycate in treatment of severe extrinsic or intrinsic bronchial asthma in adults. Br Med J 1972; 4: 383–8. 37 Chai H, Molk L, Falliers CJ, Miklich D. Steroid-sparing effects of disodium cromoglyate (DSCG) in children with severe chronic asthma. In: Serafiniu, ed. New concepts in allergy and clinical immunology. Amsterdam : Excerpta Medica, 1971: 385–91. 38 Toogood JH, Jennings B, Lefcoe NM. A clinical trial of combined cromolyn/beclomethasone treatment for chronic asthma. J Allergy Clin Immunol 1981; 67: 317–24. 39 Northern General Hospital, Brompton Hospital and Medical Research Council Collaborative Trial. Sodium cromoglycate in chronic asthma. Br Med J 1976; 1: 361–4. 40 Silverman M, Connelly N, Balfour-Lynn L, Godfrey S. Long term trial of disodium cromoglycate and isoprenaline in children with asthma. Br Med J 1972; 3: 378–81. 41 Godfrey S, Balfour-Lynn L, Konig P. The place of cromolyn sodium in the long term management of childhood asthma based on a 3 to 5 year follow-up. J Pediatr 175; 87: 465–73. 42 Lozewicz S, Robertson CF, Costello JF, Price JF. Delivery of sodium cromoglycate by pressurized aerosol. Clin Allergy 1984; 14: 187–91. 43 Hiller EJ, Milner AD, Lenney W. Nebulised sodium cromoglycate in young asthmatic children. Arch Dis Child 1977; 52: 875–6. 44 Brown LA, Kaplan RA, Benjamin PA, Hoffman LS, Shearer WT. Immunoglobulin E-mediated anaphylaxis with inhaled cromolyn sodium. J Allergy Clin Immunol 1981; 68: 416–20. 45 Godfrey S. The relative merits of cromolyn sodium and high dose theophylline therapy in childhood asthma. J Allergy Clin Immunol 1980; 65: 97–104. 46 Berman BA. Cromolyn: Past, present and future. Pediatr Clin North Am 1983; 30: 915–30. 47 Craps L, Greenwood C, Radielovich P. Clinical investigation of agents with prophylactic anti-allergic effects in bronchial asthma. Clin Allergy 1978; 8: 373–82. 48 Warner JO, Goldsworth SJ. Ketotifen in childhood allergic disease. Clin Allergy 1982; 12 (suppl): 21–7. 49 Walker SR. The fate of [14C] disodium cromoglycate in man. J Pharm Pharmacol 1972; 24: 525–31. 50 Eiser N. H1 antihistamines. In: DR Buckle, H Smith, eds. Development of anti-asthma drugs. London : Butterworths, 1984: 121–31. 51 Watt GD, Bui TC, Bewtra AK, Townley RG. Protective effects of lodoxamide tromethamine on allergen inhalation challenge. J Allergy Clin Immunol 1980; 66: 286–94. 52 Mann JS, Clement P, Sheridan AQ, Soryal I, Fairfax AJ, Holgate ST. Inhaled lodoxamide tromethamine in the treatment of perennial asthma: A double blind placebo controlled study. J Allergy Clin Immunol 1985 (in press). Citing Literature Volume15, Issue4July 1985Pages 311-320 ReferencesRelatedInformation" @default.
• W2014293735 created "2016-06-24" @default.
• W2014293735 creator A5005311406 @default.
• W2014293735 creator A5026356401 @default.
• W2014293735 date "1985-07-01" @default.
• W2014293735 modified "2023-10-16" @default.
• W2014293735 title "Sodium cromoglycate and related drugs" @default.
• W2014293735 cites W1584782374 @default.
• W2014293735 cites W1976480241 @default.
• W2014293735 cites W1981567893 @default.
• W2014293735 cites W1983183447 @default.
• W2014293735 cites W1984095026 @default.
• W2014293735 cites W1990014438 @default.
• W2014293735 cites W2001728531 @default.
• W2014293735 cites W2004514622 @default.
• W2014293735 cites W2005338863 @default.
• W2014293735 cites W2009689591 @default.
• W2014293735 cites W2010120073 @default.
• W2014293735 cites W2016451913 @default.
• W2014293735 cites W2019802752 @default.
• W2014293735 cites W2020907794 @default.
• W2014293735 cites W2021922874 @default.
• W2014293735 cites W2033109220 @default.
• W2014293735 cites W2033538296 @default.
• W2014293735 cites W2037989587 @default.
• W2014293735 cites W2047332912 @default.
• W2014293735 cites W2048995438 @default.
• W2014293735 cites W2052169710 @default.
• W2014293735 cites W2060249262 @default.
• W2014293735 cites W2062476541 @default.
• W2014293735 cites W2066902695 @default.
• W2014293735 cites W2070948266 @default.
• W2014293735 cites W2080181402 @default.
• W2014293735 cites W2089381207 @default.
• W2014293735 cites W2091755919 @default.
• W2014293735 cites W2102617857 @default.
• W2014293735 cites W2117874768 @default.
• W2014293735 cites W2122275055 @default.
• W2014293735 cites W2413149386 @default.
• W2014293735 cites W2414257402 @default.
• W2014293735 cites W2432852528 @default.
• W2014293735 cites W3023581809 @default.
• W2014293735 cites W4244536743 @default.
• W2014293735 cites W4255275549 @default.
• W2014293735 cites W2016683030 @default.
• W2014293735 doi "https://doi.org/10.1111/j.1365-2222.1985.tb02998.x" @default.
• W2014293735 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/3928196" @default.
• W2014293735 hasPublicationYear "1985" @default.
• W2014293735 type Work @default.
• W2014293735 sameAs 2014293735 @default.
• W2014293735 citedByCount "26" @default.
• W2014293735 countsByYear W20142937352013 @default.
• W2014293735 countsByYear W20142937352018 @default.
• W2014293735 crossrefType "journal-article" @default.
• W2014293735 hasAuthorship W2014293735A5005311406 @default.
• W2014293735 hasAuthorship W2014293735A5026356401 @default.
• W2014293735 hasConcept C203014093 @default.
• W2014293735 hasConcept C2776042228 @default.
• W2014293735 hasConcept C2909531985 @default.
• W2014293735 hasConcept C2911192292 @default.
• W2014293735 hasConcept C71924100 @default.
• W2014293735 hasConcept C98274493 @default.
• W2014293735 hasConceptScore W2014293735C203014093 @default.
• W2014293735 hasConceptScore W2014293735C2776042228 @default.
• W2014293735 hasConceptScore W2014293735C2909531985 @default.
• W2014293735 hasConceptScore W2014293735C2911192292 @default.
• W2014293735 hasConceptScore W2014293735C71924100 @default.
• W2014293735 hasConceptScore W2014293735C98274493 @default.
• W2014293735 hasIssue "4" @default.
• W2014293735 hasLocation W20142937351 @default.
• W2014293735 hasLocation W20142937352 @default.
• W2014293735 hasOpenAccess W2014293735 @default.
• W2014293735 hasPrimaryLocation W20142937351 @default.
• W2014293735 hasRelatedWork W142341498 @default.
• W2014293735 hasRelatedWork W1964546066 @default.
• W2014293735 hasRelatedWork W1975682430 @default.
• W2014293735 hasRelatedWork W2009689591 @default.
• W2014293735 hasRelatedWork W2058357714 @default.
• W2014293735 hasRelatedWork W2398254769 @default.
• W2014293735 hasRelatedWork W2409833736 @default.
• W2014293735 hasRelatedWork W2421499045 @default.
• W2014293735 hasRelatedWork W2467251058 @default.
• W2014293735 hasRelatedWork W4240764495 @default.
• W2014293735 hasVolume "15" @default.
• W2014293735 isParatext "false" @default.
• W2014293735 isRetracted "false" @default.
• W2014293735 magId "2014293735" @default.
• W2014293735 workType "article" @default.